Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 0.49 |
| ▸ | OPRD1 | P41143 | 3/20 | 0.49 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.49 |
| ▸ | NPY1R | P25929 | 1/20 | 0.49 |
| ▸ | NPY2R | P49146 | 1/20 | 0.49 |
| ▸ | NPY4R | P50391 | 1/20 | 0.49 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17722474 | 0.96 | OPRM1 (0.52) | OPRM1OPRD1OPRK1 | |
| SCHEMBL17722494 | 0.94 | OPRM1 (0.56) | OPRM1OPRD1OPRK1 | |
| SCHEMBL17722503 | 0.92 | OPRM1 (0.49) | OPRM1OPRD1OPRK1 | |
| SCHEMBL17722487 | 0.91 | SLC6A2 (0.52) | OPRM1OPRD1OPRK1 | |
| SCHEMBL17722475 | 0.90 | OPRM1 (0.55) | OPRM1OPRD1OPRK1 | |
| SCHEMBL17722504 | 0.88 | ANPEP (0.55) | — | |
| SCHEMBL17722501 | 0.88 | OPRM1 (0.47) | OPRM1OPRD1 | |
| SCHEMBL17722488 | 0.88 | OPRM1 (0.49) | OPRM1OPRD1OPRK1 | |
| SCHEMBL17722493 | 0.85 | OPRM1 (0.56) | OPRM1OPRD1OPRK1 | |
| SCHEMBL17722485 | 0.85 | OPRM1 (0.56) | OPRM1OPRD1OPRK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160122383-A1 | Peptide Ligation | THE UNIVERSITY OF SYDNEY (AU) | 2016-05-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160122383-A1 | Peptide Ligation | PTMS, PTMA, QPCTL | OPRM1 1164/4885OPRD1 806/4885OPRK1 1762/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.